Navigation Links
Cardium Reports Positive Data From Matrix Phase 2b Study of Excellarate(TM) Topical Gel for Non-Healing Diabetic Foot Ulcers and Plans for Phase 3 Program
Date:10/14/2009

bserved in immunological antibody responses to either collagen or to the adenovector in patients receiving Excellarate as compared to those receiving only standard of care. These findings together with the initial healing rate change over time observed in the Phase 2b study support allowing investigators in future studies to re-dose a subset of patients who have not yet achieved a prespecified rate or extent of wound closure. As a result, subject to review with the FDA, we would consider the inclusion of a re-dosing protocol into the planned Phase 3 clinical study program. Cardium believes that this added feature may offer the potential to further enhance efficacy in practical real world clinical settings by optimizing the interaction between Ad5PDGF-B production, which is believed to occur predominantly over the first few weeks following administration, with the individual patient's underlying physiology within the wound site.

Planned Phase 3 Clinical Program

Following completion of the Phase 2b study's durability phase and a complete statistical data analysis, Cardium plans to meet with the FDA to review the complete clinical trial results and to review the Company's proposed Phase 3 clinical study program. The Company will seek to establish a clinical development plan, which could include a special protocol agreement, to define the size and scope of the proposed program which will be based on the important information acquired from the Phase 1/2 and Phase 2b clinical studies. Based on FDA guidance documents and other clinical studies that have supported other product registrations, the Phase 3 program will include a prospective, randomized, double-blind, controlled multi-center study that will evaluate continued safety and definitive efficacy. Cardium is also planning that this study program will utilize a single primary efficacy endpoint, percent of complete wound closure at 12 weeks or earlier, as compared to standard of care. '/>"/>

SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Cardium Announces Commercial Development of Excellagen(TM) a Customized Collagen-Based Topical Gel for Initial Use as an Adjunct to Surgical Debridement in Patients With Diabetic Foot Ulcers
2. Scientific Journal Gene Therapy Reports That Cardiums Gene Activated Matrix Technology Accelerates Periodontal Tissue Regeneration
3. Cardium Reports on Second Quarter 2009 Financial Results and Recent Developments
4. Cardium Completes Sale of InnerCool Therapies Business to Royal Philips Electronics
5. Cardium Receives Preliminary Notification of Inclusion in the Russell 3000(R) Index and Russell Global(R) Index
6. Cardium Presents Gene Activated Matrix Technology and Update on Excellarate Clinical Development Program at ASGT Annual Meeting
7. Cardium Reports on First Quarter 2009 Financial Results and Recent Developments
8. Cardium Reports on New Excellarate(TM) Product Formulations to Expand Commercialization Potential Into Multiple Wound Healing Applications
9. Cardium Provides Update Regarding Exchange Listing Compliance Plan Accepted by NYSE Amex
10. Cardiums InnerCool Announces Journal of Neurotrauma Highlights Hypothermia Therapys Role in Post Cardiac Arrest, and Traumatic Brain and Spinal Cord Injury Patients
11. Cardium Reports on Recent Highlights, Financial Results and 2009 Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... the children at Father’s Home come from different backgrounds ... to mar their respective psychosocial development. There appears to ... has underpinnings in a healthy adolescence and in this ... foreseeable future, would assist in developing the youth. , ... of Foundation members in that remote location – as ...
(Date:7/30/2014)... Kathleen Doheny HealthDay ... Dieting at a young age might set the stage for ... Surveys of college-age women conducted from 1982 to 2012 ... and alcohol abuse. "The younger a woman was when ... [later] to use extreme weight control behaviors -- like vomiting ...
(Date:7/30/2014)... Dennis Thompson HealthDay Reporter ... fruits and vegetables are vital to good health and a ... hit five servings of fruits and vegetables each day, additional ... review suggests. The human body may only be able ... every day, limiting its ability to absorb important nutrients from ...
(Date:7/30/2014)... (USP) have identified an RNA known as INXS that, ... protein, modulates the action of an important gene in ... , According to Sergio Verjovski-Almeida, professor at the USP ... So Paulo Research Foundation (FAPESP), INXS expression is generally ... of stimulating the production of this non-coding RNA can ...
(Date:7/30/2014)... Florida A&M University ( FAMU ) ... professor Ngozi Ugochukwu, Ph.D., will head to Nigeria ... The prestigious Fulbright Scholars Program is a highly ... to students, faculty or professionals who wish to ... and Ugochukwu will conduct respective research on the ...
Breaking Medicine News(10 mins):Health News:The Edusei Foundation Donates Food and Assorted Items to the Fathers’ Home Care Ministries in Takoradi, Ghana 2Health News:Dieting at Young Age Often Backfires, Study Says 2Health News:Dieting at Young Age Often Backfires, Study Says 3Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 2Health News:Fruits, Veggies May Have Their Limits in Boosting Lifespan 3Health News:Brazilian researchers identify RNA that regulates cell death 2Health News:Brazilian researchers identify RNA that regulates cell death 3Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 2Health News:FAMU Professor and Engineering Student Named Fulbright Scholars 3
... useless, the appendix now appears to have a reason to ... living in the human gut. , Drawing upon a series ... that the beneficial bacteria in the appendix that aid digestion ... the intestines and emerge afterwards to repopulate the gut. Their ...
... insights into chronic, illnesses, including heart failure and COPD, from ... ... Calif., Oct. 8 VivoMetrics announced today,that noted researcher Bruce D. Johnson, ... LifeShirt(R) System to,the South Pole to collect valuable data for his ongoing ...
... Prescription Pads with ... Enhanced Patient Features, HASBROUCK ... prescription pads, today announced that,it has appointed Richard Zwickel to ... model. Being launched this,month at the PDMA Sharing Conference in ...
... mothers who survived ... breast cancer, ALPHARETTA, Ga., ... brand, celebrates the "Power of Pink" by,announcing the winners of its "Pink ... women will be recognized,during the Susan G. Komen for the Cure Pink ...
... scrapes and bruises, study found , MONDAY, Oct. 8 (HealthDay ... as a non-lethal way to incapacitate suspects, are generally safe ... say U.S. researchers who reviewed almost 1,000 incidents involving the ... to a Taser had mild injuries (such as scrapes and ...
... to More Than Half the Population of Singapore to Use ... ... Facilities -, BOCA RATON, Fla., ... today announced,that SingHealth, the largest healthcare provider in Singapore, has selected,Eclipsys ...
Cached Medicine News:Health News:Appendix isn't useless at all: It's a safe house for bacteria 2Health News:Appendix isn't useless at all: It's a safe house for bacteria 3Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 2Health News:VivoMetrics' LifeShirt Going to South Pole to Uncover Clues to High-Altitude Illness 3Health News:Medi-Promotions Hires Industry Executive to Expand its Medi-Scripts Prescription Pad Model 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 2Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 3Health News:'Pink Power Moms' Unite in Atlanta for Day of Pampering and Recognition 4Health News:Serious Injury Rare With Police Tasers 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 2Health News:SingHealth Selects Eclipsys Solutions to Help Improve Clinical Outcomes, First Sunrise Clinical Manager Client Outside of North America 3
(Date:7/30/2014)... Coordinators, Inc. (PCI) is pleased to announce it has ... Limited (Penn Pharma). Penn Pharma is headquartered in Tredegar, ... Kingdom and operates regional offices in ... Tokyo , Japan. Penn Pharma offers both drug development ... manufacturing, as well as Clinical Packaging, Labeling, and global ...
(Date:7/30/2014)... FOREST, Ill., July 30, 2014  Hospira, Inc. ... provider of injectable drugs and infusion technologies, today ... 30, 2014. Net sales for the quarter were ... were $0.72. (Adjusted* measures exclude specified items as ... attached schedules.) On a U.S. Generally Accepted Accounting ...
(Date:7/30/2014)... VILLAGE, Nev. , July 30, 2014  PDL ... announced that company management will participate in the Jefferies ... Boston , Massachusetts. The conference will occur on August ... About PDL BioPharma, Inc. PDL BioPharma manages ... of its Queen et al. antibody humanization patents and ...
Breaking Medicine Technology:PCI Announces Definitive Agreement to Acquire Penn Pharma 2PCI Announces Definitive Agreement to Acquire Penn Pharma 3PCI Announces Definitive Agreement to Acquire Penn Pharma 4PCI Announces Definitive Agreement to Acquire Penn Pharma 5Hospira Reports Second-Quarter 2014 Results 2Hospira Reports Second-Quarter 2014 Results 3Hospira Reports Second-Quarter 2014 Results 4Hospira Reports Second-Quarter 2014 Results 5Hospira Reports Second-Quarter 2014 Results 6Hospira Reports Second-Quarter 2014 Results 7Hospira Reports Second-Quarter 2014 Results 8Hospira Reports Second-Quarter 2014 Results 9Hospira Reports Second-Quarter 2014 Results 10Hospira Reports Second-Quarter 2014 Results 11Hospira Reports Second-Quarter 2014 Results 12Hospira Reports Second-Quarter 2014 Results 13Hospira Reports Second-Quarter 2014 Results 14Hospira Reports Second-Quarter 2014 Results 15Hospira Reports Second-Quarter 2014 Results 16Hospira Reports Second-Quarter 2014 Results 17Hospira Reports Second-Quarter 2014 Results 18Hospira Reports Second-Quarter 2014 Results 19Hospira Reports Second-Quarter 2014 Results 20Hospira Reports Second-Quarter 2014 Results 21Hospira Reports Second-Quarter 2014 Results 22Hospira Reports Second-Quarter 2014 Results 23Hospira Reports Second-Quarter 2014 Results 24Hospira Reports Second-Quarter 2014 Results 25Hospira Reports Second-Quarter 2014 Results 26Hospira Reports Second-Quarter 2014 Results 27Hospira Reports Second-Quarter 2014 Results 28Hospira Reports Second-Quarter 2014 Results 29Hospira Reports Second-Quarter 2014 Results 30Hospira Reports Second-Quarter 2014 Results 31PDL BioPharma to Participate in Jefferies 2014 Boston Healthcare Summit 2
... Surgical Company (Nasdaq: STAA ), a leading ... today announced that it expects revenue for the fourth ... Revenues for the full year were approximately $55 million, ... increase of approximately 10% in revenues from the core ...
... Nalco (NYSE: NLC ), providing essential ... Water and Process Services division is implementing a price ... or as contracts permit.  Pricing for most Nalco programs ... product mix. Price increases will vary by country and ...
Cached Medicine Technology:STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 2STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 3STAAR Surgical Announces Fourth Quarter 2010 Revenue Expected to Exceed $14.2 Million 4Nalco Announces Price Increase 2Nalco Announces Price Increase 3
This versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
HST, versatile convex array abdominal transducer is multi-frequency, offering 5 levels of fundamental frequencies in addition to 4 settings of Harmonic frequencies. This transducer provides superb im...
... is ALOKAs answer to the ... Super High Density, versatile convex ... offering 5 levels of fundamental ... settings of Harmonic frequencies. This ...
The versatility of multiple imaging frequencies and a smaller transducer face make this transducer is perfect for intercostal imaging....
Medicine Products: